The Business Times
SUBSCRIBERS

Tharman: S'pore will continue to invest in biomedical sector

google-preferred-sourceAdd BT as a preferred source
Published Wed, Mar 11, 2015 · 09:50 PM

    Singapore

    SINGAPORE will continue to invest to stay at the forefront of the biomedical sciences industry, even as the sector generated output of S$21.5 billion last year and employed 16,800 people, said Deputy Prime Minister Tharman Shanmugaratnam.

    He made the point on Wednesday at a ground-breaking ceremony where drugmaker GlaxoSmithKline (GSK) said that it would set up a new global headquarters for Asia in Singapore, as it looks to the emerging markets to grow its business.

    Tharman ShanmugaratnamGlaxoSmithKlineboustead singapore

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More